Elos Medtech AB (ELOS B):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Elos Medtech AB (ELOS B) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7004
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Elos Medtech AB (Elos Medtech) is a partner in development and manufacturer of medical devices and components. The company’s products include dental and orthopedic implants and instruments. It offers diagnostic devices used in the treatment of diabetes, neurosurgery, heart surgery and hearing aids. Elos Medtech also offers designing, prototype, testing, and packaging services. The company serves dental implant systems, trauma and spine, diagnostics and delivery systems, among other markets. It has operational facilities in Sweden, Denmark, China and the US. Elos Medtech is headquartered in Goteborg, Sweden.

Elos Medtech AB (ELOS B) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Elos Medtech AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Elos Medtech AB, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Elos Medtech AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Elos Medtech AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Elos Medtech AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Elos Medtech AB, Medical Equipment, Deal Details 10
Asset Purchase 10
Elos Medtech to Acquire Cresco System from Dentsply Implants 10
Equity Offering 11
Elos Medtech Raises USD13 Million in Rights Offering of Shares 11
Acquisition 12
Elos Acquires Onyx Medical 12
Elos Medtech AB – Key Competitors 13
Elos Medtech AB – Key Employees 14
Elos Medtech AB – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Financial Announcements 16
Jul 19, 2018: Elos Medtech interim report January 1 – June 30, 2018 16
Apr 24, 2018: Elos Medtech – Interim report January 1 – March 31, 2018 18
Oct 25, 2017: Elos Medtech: Interim report 1 January – 30 September, 2017 20
Aug 25, 2017: Elos Medtech Interim Report January 1 – June 30, 2017 22
Apr 26, 2017: Elos Medtech Interim report, 1 January – 31 March, 2017 23
Feb 24, 2017: Elos net sales increases 10.1% in 2016 25
Corporate Communications 26
May 14, 2018: Managing Director at Elos Medtech Timmersdala is appointed 26
Feb 15, 2018: Elos Medtech builds up a strong platform within Dental Implant Systems 27
Nov 14, 2017: Elos Medtech commits to the global orthopaedic market 28
Apr 27, 2017: Elos Medtech – Annual General Meeting 2017 29
Mar 10, 2017: Managing Director at Elos Medtech Tianjin steps down 30
Mar 03, 2017: Elos Medtech: The Nomination Committee’s proposal for new Chairman and new Board Member 31
Other Significant Developments 32
Sep 25, 2018: A new coating and surface solution for the orthopedic market 32
May 08, 2018: Elos Medtech expands Onyx Medical in the United States 33
May 07, 2018: Electrical Discharge Machining increases automation and precision in orthopedic manufacturing 34
Feb 19, 2018: Elos Medtech – Year- end report for the period 1 January to 31 December, 2017 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
Elos Medtech AB, Medical Equipment, Key Facts, 2017 2
Elos Medtech AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Elos Medtech AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Elos Medtech AB, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Elos Medtech AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Elos Medtech AB, Deals By Market, 2012 to YTD 2018 8
Elos Medtech AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Elos Medtech to Acquire Cresco System from Dentsply Implants 10
Elos Medtech Raises USD13 Million in Rights Offering of Shares 11
Elos Acquires Onyx Medical 12
Elos Medtech AB, Key Competitors 13
Elos Medtech AB, Key Employees 14
Elos Medtech AB, Subsidiaries 15

List of Figures
Elos Medtech AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Elos Medtech AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Elos Medtech AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Elos Medtech AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Elos Medtech AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Elos Medtech AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Elos Medtech AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Elos Medtech AB, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Elos Medtech AB (ELOS B):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Etiqa Life and General Assurance Philippines Inc:企業の戦略・SWOT・財務分析
    Etiqa Life and General Assurance Philippines Inc - Strategy, SWOT and Corporate Finance Report Summary Etiqa Life and General Assurance Philippines Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Sumitomo Bakelite Co Ltd (4203):企業の財務・戦略的SWOT分析
    Sumitomo Bakelite Co Ltd (4203) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Health Net Inc:企業の戦略的SWOT分析
    Health Net Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Islet Sciences Inc (ISLT):企業の財務・戦略的SWOT分析
    Summary Islet Sciences Inc (Islet Sciences) is a drug development company that develops medicines and technologies for the treatment of metabolic diseases. The company's pipeline products include immune modulating small molecule interleukin 12 inhibitors to address disorders associated with inflamma …
  • Naftna industrija Srbije ad (NIIS):企業の財務・戦略的SWOT分析
    Naftna industrija Srbije ad (NIIS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Epax Norway AS:戦略・SWOT・企業財務分析
    Epax Norway AS - Strategy, SWOT and Corporate Finance Report Summary Epax Norway AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Texas Biomedical Research Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Texas Biomedical Research Institute (Texas Biomed) is a medical research institute that develops treatment for chronic and infectious diseases. The institute conducts biomedical research and discovers new technologies for preventing and eradicating infectious diseases. Its research program i …
  • Erbud SA:企業の戦略・SWOT・財務情報
    Erbud SA - Strategy, SWOT and Corporate Finance Report Summary Erbud SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • JFE Holdings, Inc. (5411):企業の財務・戦略的SWOT分析
    JFE Holdings, Inc. (5411) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Batu Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Batu Biologics Inc (Batu Biologics) is an immuno-oncology company. The company offers development and commercialization of novel therapies that target the Achilles Heel of cancer: the tumor blood vessels. Its lead product ValloVax is a cellular anti-angiogenic cancer vaccine that is develope …
  • Tohoku Electric Power Co Inc:発電所・企業SWOT分析
    Tohoku Electric Power Co Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Medical Properties Trust, Inc.:企業のM&A・事業提携・投資動向
    Medical Properties Trust, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Medical Properties Trust, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Oxiteno SA Industria E Comercio:企業の戦略的SWOT分析
    Oxiteno SA Industria E Comercio - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Terumo BCT Inc:企業の戦略的SWOT分析
    Terumo BCT Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • The Timken Company
    The Timken Company - Strategy, SWOT and Corporate Finance Report Summary The Timken Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Amgen Inc (AMGN):医療機器:M&Aディール及び事業提携情報
    Summary Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to improve the lives of patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncol …
  • PT Sinar Mas Agro Resources and Technology Tbk (SMAR):企業の財務・戦略的SWOT分析
    PT Sinar Mas Agro Resources and Technology Tbk (SMAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s …
  • Municipal Energy Agency of Nebraska:企業の戦略的SWOT分析
    Municipal Energy Agency of Nebraska - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • CytImmune Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CytImmune Sciences Inc (CytImmune) is a clinical stage nanomedicine company that discovers, develops, and commercializes tumor-targeted therapies. The company develops nanotherapy platform, Aurimune, a tumor-targeted trojan horse. Its Aurimune binds TNF receptors on blood vessel cells at the …
  • IBIDEN Co Ltd (4062):企業の財務・戦略的SWOT分析
    IBIDEN Co Ltd (4062) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆